Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects

ClinicalTrials.gov ID: NCT01301066

Public ClinicalTrials.gov record NCT01301066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 4:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects With Dyslipidemia, Followed by a 40-Week Safety Extension Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study.

Study identification

NCT ID
NCT01301066
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Kowa Research Institute, Inc.
Industry
Enrollment
252 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2010 (Type not available)
Primary completion
Mar 2013 (Actual)
Completion
Mar 2013 (Actual)
Last update posted
Apr 29, 2014

2010 – 2013

United States locations

U.S. sites
35
U.S. states
14
U.S. cities
35
Facility City State ZIP Site status
Not listed Phoenix Arizona — —
Not listed Beverly Hills California — —
Not listed Costa Mesa California — —
Not listed Long Beach California — —
Not listed Los Angeles California — —
Not listed Newport Beach California — —
Not listed San Francisco California — —
Not listed Washington D.C. District of Columbia — —
Not listed Coral Gables Florida — —
Not listed Fort Lauderdale Florida — —
Not listed Ft. Pierce Florida — —
Not listed Miami Florida — —
Not listed Miami Beach Florida — —
Not listed Tampa Florida — —
Not listed Vero Beach Florida — —
Not listed Atlanta Georgia — —
Not listed Decatur Georgia — —
Not listed Springfield Massachusetts — —
Not listed Berkley Michigan — —
Not listed St Louis Missouri — —
Not listed Hillsborough New Jersey — —
Not listed Randolph Township New Jersey — —
Not listed New York New York — —
Not listed Rochester New York — —
Not listed Huntersville North Carolina — —
Not listed Addison Texas — —
Not listed Austin Texas — —
Not listed Corpus Christi Texas — —
Not listed Fort Worth Texas — —
Not listed Harlingen Texas — —
Not listed Houston Texas — —
Not listed Longview Texas — —
Not listed Annandale Virginia — —
Not listed Seattle Washington — —
Not listed Spokane Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01301066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2014 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01301066 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →